Skip to main content

Concurrent assessment of vasculature and proliferative pharmacodynamics in patients treated with VEGFR TKI.

Publication ,  Journal Article
Jeraj, R; Liu, G; Simoncic, U; Vanderhoek, M; Perlman, S; Alberti, DB; Harrison, MR; Wilding, G
Published in: Journal of Clinical Oncology
May 20, 2010

Duke Scholars

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2010

Volume

28

Issue

15_suppl

Start / End Page

3050 / 3050

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Jeraj, R., Liu, G., Simoncic, U., Vanderhoek, M., Perlman, S., Alberti, D. B., … Wilding, G. (2010). Concurrent assessment of vasculature and proliferative pharmacodynamics in patients treated with VEGFR TKI. Journal of Clinical Oncology, 28(15_suppl), 3050–3050. https://doi.org/10.1200/jco.2010.28.15_suppl.3050
Jeraj, R., G. Liu, U. Simoncic, M. Vanderhoek, S. Perlman, D. B. Alberti, M. R. Harrison, and G. Wilding. “Concurrent assessment of vasculature and proliferative pharmacodynamics in patients treated with VEGFR TKI.Journal of Clinical Oncology 28, no. 15_suppl (May 20, 2010): 3050–3050. https://doi.org/10.1200/jco.2010.28.15_suppl.3050.
Jeraj R, Liu G, Simoncic U, Vanderhoek M, Perlman S, Alberti DB, et al. Concurrent assessment of vasculature and proliferative pharmacodynamics in patients treated with VEGFR TKI. Journal of Clinical Oncology. 2010 May 20;28(15_suppl):3050–3050.
Jeraj, R., et al. “Concurrent assessment of vasculature and proliferative pharmacodynamics in patients treated with VEGFR TKI.Journal of Clinical Oncology, vol. 28, no. 15_suppl, American Society of Clinical Oncology (ASCO), May 2010, pp. 3050–3050. Crossref, doi:10.1200/jco.2010.28.15_suppl.3050.
Jeraj R, Liu G, Simoncic U, Vanderhoek M, Perlman S, Alberti DB, Harrison MR, Wilding G. Concurrent assessment of vasculature and proliferative pharmacodynamics in patients treated with VEGFR TKI. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010 May 20;28(15_suppl):3050–3050.

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2010

Volume

28

Issue

15_suppl

Start / End Page

3050 / 3050

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences